Doctors determine the stage of leukemia by evaluating factors such as the number of leukemia cells in the blood and bone marrow, the spread of leukemia to other parts of the body, and the person’s ...
Researchers used various sequencing technologies to explore the molecular characteristics of myeloid/natural killer cell precursor acute leukemia (MNKPL). They observed activation of the NOTCH1 and ...
A little over a month after revealing to the world that she'd been diagnosed with cancer, Tatiana Schlossberg has died at age 35. "Our beautiful Tatiana passed away this morning," her family wrote in ...
Mixed phenotype acute leukemia has qualities of both lymphoid and myeloid leukemias. These mixed qualities make it very difficult to diagnose and treat. The outlook for people with this type of ...
Q: My mother was diagnosed with CLL two years ago. She started chemotherapy. The drug ratuximab is her current chemotherapy drug. She has also developed lymphoma. Approximately six months ago she ...
Biphenotypic leukemia is a mixed type of leukemia that originates in both lymphoid and myeloid cells. It typically has a poorer outlook than other acute leukemias. A stem cell transplant may improve ...
September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...
Share on Pinterest Scientists are testing new drugs to treat different types of leukemia. Luis Velasco/Stocksy More than 474,000 people globally have leukemia, and acute leukemia is the most ...
Researchers have identified a possible new targeted drug for treating acute myeloid leukemia. In the future, the discovery may help patients with certain rare subtypes of the disease. Targeted drugs ...
Health on MSN

How Is Leukemia Diagnosed?

Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow. It affects cells that develop into ...
Researchers of the Hospital Universitario 12 de Octubre in Madrid and the Josep Carreras Leukaemia Research Institute have developed a cell therapy for a type of leukemia which currently has very few ...